Retinoic Acid Treatment Increases Lipid Oxidation Capacity in Skeletal Muscle of Mice

Laboratory of Molecular Biology, Nutrition and Biotechnology, Universitat de les Illes Balears, Palma de Mallorca, Spain.
Obesity (Impact Factor: 3.73). 04/2008; 16(3):585-91. DOI: 10.1038/oby.2007.104
Source: PubMed


All-trans retinoic acid (ATRA), a carboxylic form of vitamin A, favors in mice a mobilization of body fat reserves that correlates with an increment of oxidative and thermogenic capacity in adipose tissues. The objective of this study has been to investigate the effect of ATRA treatment on skeletal muscle capacity for fatty-acid catabolism.
Tissue composition and gene expression related to lipid and oxidative metabolism were analyzed in skeletal muscle of mice acutely treated with ATRA or vehicle (olive oil).
ATRA treatment triggered a dose-dependent increase in the muscle mRNA expression levels of selected enzymes, transporters and transcription factors involved in fatty-acid oxidation, respiration, and thermogenesis namely: muscle-type carnitine palmitoyltransferase 1, acyl CoA oxidase 1, subunit II of cytochrome oxidase, uncoupling protein 3, peroxisome proliferator-activated receptor-gamma co-activator -1alpha and peroxisome proliferator-activated receptor-delta (PPARdelta). The treatment also resulted in the upregulation of the mRNA levels of acetyl-CoA carboxylase 2 (ACC2), a key regulatory enzyme for mitochondrial fatty-acid oxidation in muscle. Skeletal muscle protein levels of PPARdelta and retinoid X receptor gamma, a partner for many nuclear receptors involved in lipid metabolism, were increased after ATRA treatment. Muscle lipid content was decreased.
These results indicate that ATRA treatment increases the capacity of skeletal muscle for fatty-acid oxidation. Knowledge of nutrients or nutrient-derivatives capable of enhancing oxidative metabolism in muscle and other tissues can contribute to new avenues of prevention and treatment of obesity and related disorders.

Download full-text


Available from: M. Luisa Bonet, Apr 29, 2014
48 Reads
  • Source
    • "Retinoic acid-vitamin A metabolites exerts a number of essential biological functions through activation of two classes of nuclear receptors , RAR (α, β and γ), which respond to all-trans retinoic acid (ATRA) and 9-cis-isomers of RA; and RXR (α, β and γ), which are activated by 9-cis-RA exclusively. Studies have shown that ATRA inhibits the development of type 1 diabetes [6]; and reduces body weight and adiposity through regulation of lipid metabolism in the adipose tissue, liver and skeletal muscle of mice [7] [8] [9]. RXR agonists also have anti-diabetic effects in type 2 diabetic mouse models [10]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Diabetic cardiomyopathy (DCM) is a significant contributor to the morbidity and mortality associated with diabetes and metabolic syndrome. Retinoids, through activation of retinoic acid receptor (RAR) and retinoid x receptor (RXR), have been linked to control of glucose and lipid homeostasis, with effects on obesity and diabetes. However, the functional role of RAR and RXR in the development of DCM remains unclear. Zucker diabetic fatty (ZDF) and lean rats were treated with Am580 (RARα agonist) or LGD1069 (RXR agonist) for 16 weeks, and cardiac function and metabolic alterations were determined. Hyperglycemia, hyperlipidemia and insulin resistance were observed in ZDF rats. Diabetic cardiomyopathy was characterized in ZDF rats by increased oxidative stress, apoptosis, fibrosis, inflammation, activation of MAP kinases and NF-κB signaling and diminished Akt phosphorylation, along with decreased glucose transport and increased cardiac lipid accumulation, and ultimately diastolic dysfunction. Am580 and LGD1069 attenuated diabetes-induced cardiac dysfunction and the pathological alterations, by improving glucose tolerance and insulin resistance; facilitating Akt activation and glucose utilization, and attenuating oxidative stress and interrelated MAP kinase and NF-κB signaling pathways. Am580 inhibited body weight gain, attenuated the increased cardiac fatty acid uptake, β-oxidation and lipid accumulation in the hearts of ZDF rats. However, LGD1069 promoted body weight gain, hyperlipidemia and cardiac lipid accumulation. In conclusion, our data suggest that activation of RAR and RXR may have therapeutic potential in the treatment of diabetic cardiomyopathy. However, further studies are necessary to clarify the role of RAR and RXR in the regulation of lipid metabolism and homeostasis.
    Journal of Molecular and Cellular Cardiology 02/2013; 57(1). DOI:10.1016/j.yjmcc.2013.01.017 · 4.66 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper presents the design of a mounting plate with a complex permittivity profile that minimizes the reflection from the mounting plate over a broad range of incidence angles while providing the mechanical rigidity necessary for mounting a styrofoam jig holding the device under test. The geometry is reminiscent of a honeycomb structure, and is modeled as a uniaxial medium with the optic axis parallel to the normal of the plate. A modified scattering matrix propagator scheme was developed to predict the reflection and the transmission coefficients for both the TE<sup>z</sup> and TM<sup>z</sup> polarizations in a way that takes into account explicitly both the non-uniform wave propagation resulting from the presence of material losses, and the longitudinal anisotropy resulting from the geometry of the machined plate. A choice of parameters that yields a predicted reflection level of less than -20 dB from 0° to 55° is presented
    Antennas and Propagation Society International Symposium, 2001. IEEE; 02/2001
  • [Show abstract] [Hide abstract]
    ABSTRACT: Adipose-derived retinol binding protein 4 (RBP4) might contribute to the development of insulin resistance, and therefore further knowledge of factors regulating it is of interest. Retinoic acid, the acid form of vitamin A, affects the expression of several adipokines related to insulin sensitivity in mice. Here, we sought to investigate its impact on adipose RBP4 production. Changes in RBP4 expression were analyzed in adipose tissues and liver of mice treated in vivo with all-trans retinoic acid (ATRA), and in 3T3-L1 adipocytes and adipocytes derived from mouse embryonic fibroblasts exposed to ATRA. ATRA treatment in mice increased insulin sensitivity as assessed by the homeostatic model assessment for insulin resistance, and led to a reduction of RBP4 mRNA and protein levels in adipose tissues, a reduction of RBP4 protein but not RBP4 mRNA levels in the liver, and a marked increase in circulating RBP4 protein levels. In adipocyte cell models, ATRA down-regulated RBP4 mRNA levels in a dose-dependent manner: this effect was reproduced by retinaldehyde and retinoid receptors agonists, and correlated with a reduced accumulation of RBP4 protein in the culture medium. These results reveal a selective effect of ATRA inhibiting RBP4 expression specifically in adipocytes, and reinforce the concept that vitamin A vitamers may affect insulin sensitivity through effects on adipokine production.
    Cellular Physiology and Biochemistry 02/2008; 22(1-4):363-72. DOI:10.1159/000149815 · 2.88 Impact Factor
Show more